Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Decitabine may help myelodysplastic cells become more like normal stem cells.
PURPOSE: This clinical trial studies differentiation therapy with decitabine in treating
patients with myelodysplastic syndrome.